Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 4/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27649423 | 0.97 | KCNN4 (0.46) | KCNN4TAAR1MAPK1ALDH1A1TSHR | |
| SCHEMBL27836731 | 0.90 | ESR1 (0.52) | KCNN4TAAR1MAPK1ALDH1A1CYP2C19 | |
| SCHEMBL1011933 | 0.85 | KCNN4 (0.41) | KCNN4TAAR1MAPK1ALDH1A1TP53 | |
| SCHEMBL597655 | 0.85 | KCNN4 (0.41) | KCNN4TAAR1MAPK1TSHRTP53 | |
| SCHEMBL915727 | 0.85 | KCNN4 (0.41) | KCNN4TAAR1MAPK1ALDH1A1TP53 | |
| SCHEMBL6282930 | 0.85 | TAAR1 (0.54) | KCNN4TAAR1CYP3A4CYP1A2 | |
| SCHEMBL7095560 | 0.83 | CYP1A2 (0.50) | KCNN4TAAR1MAPK1TP53CYP2C19 | |
| Hydrochloric Acid SCHEMBL7857894 | 0.83 | TAAR1 (0.52) | KCNN4TAAR1CYP3A4CYP1A2 | |
| SCHEMBL25298896 | 0.81 | KIF11 (0.41) | KCNN4TAAR1ESR1ESR2 | |
| SCHEMBL17965752 | 0.81 | KCNN4 (0.39) | KCNN4TAAR1MAPK1ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180006331-A1 | NONAQUEOUS ELECTROLYTE BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2018-01-04 | — | — | US | claimed |
| CN-102142577-A | Nonaqueous electrolyte battery | SONY CORP | 2011-08-03 | — | — | CN | claimed |
| US-20110183200-A1 | NONAQUEOUS ELECTROLYTE BATTERY | SONY CORPORATION (JP) | 2011-07-28 | — | — | US | claimed |
| US-7563358-B2 | Process for the production of benzene, toluene, and xylenes | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-07-21 | — | — | US | claimed |
| US-20080254367-A1 | Anode composite of lithium oxide with cobalt oxide or nickel oxide; cathode is lithium, or alloy thereof; nonaqueous electrolyte; prevention decomposition due to overcharging | UBE INDUSTRIES, LTD. (JP) | 2008-10-16 | — | — | US | claimed |
| US-20080051615-A1 | Process for the production of benzene, toluene, and xylenes | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-02-28 | — | — | US | claimed |
| JP-5140003-A | — | — | None | — | — | JP | disclosed |
| JP-5140002-A | — | — | None | — | — | JP | disclosed |
| JP-6166641-A | — | — | None | — | — | JP | disclosed |
| JP-6166642-A | — | — | None | — | — | JP | disclosed |
| US-20260062769-A1 | METHOD OF LEACHING NICKEL FROM OXIDIZED ORE, METHOD OF MANUFACTURING NICKEL SULFATE, AND NICKEL-LEACHING AGENT | PRIME PLANET ENERGY & SOLUTIONS INC (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20260062315-A1 | METHOD OF LEACHING NICKEL FROM OXIDIZED ORE, METHOD OF MANUFACTURING NICKEL SULFATE, AND NICKEL-LEACHING AGENT | PRIME PLANET ENERGY & SOLUTIONS INC (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20240332686-A1 | TAB AND BATTERY COMPRISING TAB | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2024-10-03 | — | — | US | disclosed |
| US-4980346-A | N-ALKYL(ENE)-N-(O,O-DISUBSTITUTED-THIOPHOSPHORYL)-N',N' -SUBSTITUTED GLYCINE AMIDE DERIVATIVES | ESZAKMAGYARORSUAGI VEGYIMUVEK (HU) | 1990-12-25 | — | — | US | disclosed |
| US-4889944-A | Novel N-alkyl or N-alkenyl-N-(O,O-disubstituted-thio-phosphoryl)-N',N'-disubstituted glycin amides, process for the preparation thereof and acaricide, insecticide and fungicide containing these compounds as active ingredient | ESZAKMAGYARORSZAGI VEGYIMUVEK (HU) | 1989-12-26 | — | — | US | disclosed |
| US-4870065-A | MITICIDES | ESZAKMAGYARORSZAGI VEGYIMUVEK (HU) | 1989-09-26 | — | — | US | disclosed |
| US-4297508-A | BY REACTING CARBON DIOXIDE WITH B-NAPHTHOL, AN ALKALI METAL SALT OF B-NAPHTHOL, AND AN ALKYLBENZENE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-10-27 | — | — | US | disclosed |
| US-4202894-A | AGRICULTURE | HOFFMANN-LA ROCHE INC. (US) | 1980-05-13 | — | — | US | disclosed |
| US-4186270-A | CHLOROMETHYLATION, CONVERSION TO NITRILE, METHYLATION OR ETHYLATION, HYDROLYSIS | THE DOW CHEMICAL COMPANY (US) | 1980-01-29 | — | — | US | disclosed |
| US-3969196-A | Process for the separation of mixtures of substances | STUDIENGESELLSCHAFT KOHLE M.B.H. (DT) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062769-A1 | METHOD OF LEACHING NICKEL FROM OXIDIZED ORE, METHOD OF MANUFACTURING NICKEL SULFATE, AND NICKEL-LEACHING AGENT | HAO2, LIPA, YAP1 | KCNN4 427/4885TAAR1 2482/4885MAPK1 1746/4885 |
| US-20260062315-A1 | METHOD OF LEACHING NICKEL FROM OXIDIZED ORE, METHOD OF MANUFACTURING NICKEL SULFATE, AND NICKEL-LEACHING AGENT | SLC9A2, HAO2, SLC9A3 | KCNN4 156/4885TAAR1 3440/4885MAPK1 1018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.